Trade bodies the Association of the Pharmaceutical Industry (ABPI) and the BioIndustry Association (BIA) are moving in together into new offices in Victoria, London, later this month, marking 'a more collaborative era for life sciences' in the UK.

According to the ABPI, the move builds on its agenda to bulk up its capacity to engage with partners and members, while the BIA says it offers the opportunity to boost the country's competitive position in life sciences and expand collaborative relationships across sector.

While the organisations will retain their independence occupying separate offices on a shared floor of the building, the closer proximity will help to encourage a greater degree of joint-working on issues relevant to the entire industry, the groups said.

"Establishing a central venue where those with an interest in life sciences can access the combined expertise of the BIA and ABPI will enable us to highlight more effectively all that the UK has to offer," noted BIA chief executive Nigel Gaymond.

Since the launch of LifeSciences UK earlier this year "our organisations have been able to operate more strategically, and more effectively, by representing the life sciences sector with one voice," said ABPI director general Richard Barker, adding that the move "strengthens a joint determination that the UK remain a great place to invest and do business in life sciences".

LifeSciencesUK is an initiative involving the ABPI, BIA, British In Vitro Diagnostics Association (BIVDA) and Association of British Healthcare Industries (ABHI) designed to facilitate greater joint working across the biotechnology, pharmaceuticals, medical devices and diagnostics sectors.

The strategy behind the move is to build on the government's commitment to transform the life sciences environment in Britain, and ensure that it retains a competitive edge on a global stage.